Vanta Bioscience LtdHealthcare Research- Analytics and TechnologyINE695X01011
Valuation
Market Cap₹14.15 Cr
TTM PE448.20x
Forward PE168.08x
PEG-8.96
Book Value₹6.35
P/B3.53x
TTM EPS₹0.05
Fwd EPS₹0.13
TTM Revenue₹3.99 Cr
TTM PAT₹0.03 Cr
TTM EBITDA₹1.61 Cr
TTM EBIT₹1.04 Cr
Last Qtr PAT₹0.03 Cr
Last Qtr EBITDA₹1.61 Cr
Last Qtr EBIT₹1.04 Cr
Profitability
ROE—
ROCE—
TTM NPM0.75%
TTM EBITDA %40.35%
Curr OPM0.00%
Last OPM0.68%
Curr NPM—
Last NPM—
Curr EPS₹0.00
Last EPS₹0.05
Balance sheet
Equity—
Reserve—
Total Debt₹0.00 Cr
D/E—
Interest %0.00%
Curr Interest₹0.00 Cr
Price / range
Close₹22.41
vs 52W High-22.72%
vs 52W Low+52.35%
MA50—
MA200—
Returns
1D+9.91%
1W+9.91%
1M+9.75%
3M-1.84%
6M+21.14%
1Y-19.07%
2Y-57.88%
3Y-45.35%
5Y-82.07%
Diwali-4.64%
Sector peers — Healthcare Research- Analytics and Technology
CompanyCloseMkt CapTTM P/EROE
SYNGENE417.30₹16.81K Cr79.494.35%
INDGN609.75₹14.69K Cr65.146.70%
SUVEN264.85₹6.02K Cr-115.66-12.60%
VIMTALABS496.45₹2.22K Cr27.5716.35%
TAKE12.57₹185.95 Cr30.6618.87%
BI71.87₹169.22 Cr-107.27—
JSTL80.87₹128.05 Cr25.67—
VANTABIO22.41₹14.15 Cr448.20—

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

0 lines · 0 periods

No financial result data.

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 1 years
MetricFY 17-18
Revenue3.99
Other Income0.05
Total Income4.04
Expenditure-3.15
Interest-0.20
PBDT0.89
EBITDA1.61
Depreciation-0.57
EBIT1.04
PBT0.32
Tax-0.29
Equity5.73
OPM (%)22.25
Net Profit0.03
NPM (%)0.68
EPS (Rs)0.05
CEPS1.05

Consolidated

0 lines · 0 periods

No financial result data.

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

0 lines · 0 years

No yearly result data.

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

0

No dividend history.

Bonus

0

No bonus history.

Split

0

No split history.

Loading company dashboard...
Fetching ratios, charts, and peers